FDA.reportPublic FDA data

rivastigmine 0.192 MG/HR 24 HR Transdermal Patch

RxCUI
725021
RxNorm name
rivastigmine 0.192 MG/HR 24 HR Transdermal Patch
Display name
rivastigmine 0.192 MG/HR 24 HR Transdermal Patch
Full name
rivastigmine 0.192 MG/HR 24 HR Transdermal Patch
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:06

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 11 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RivastigmineRIVASTIGMINEZydus Lifesciences Limited966d59ea-5cea-4fef-8b96-e0efe885caf42025-11-17Exact identifier
rxcui: 725021
RivastigmineRIVASTIGMINENorthstar Rx LLC.8b809739-8381-4cc1-ab4a-5b17ab902a3d2025-11-14Warnings, Adverse reactionsExact identifier
rxcui: 725021
Rivastigmine Transdermal SystemRIVASTIGMINEBryant Ranch Prepacka7f9328e-b6da-4474-ac93-3cdd4825e1632025-04-01Warnings, Adverse reactionsExact identifier
rxcui: 725021
Rivastigmine Transdermal SystemRIVASTIGMINEBreckenridge Pharmaceutical, Inc.b201fe68-b5e5-4a6f-8cf1-069543f03e762025-01-15Warnings, Adverse reactionsExact identifier
rxcui: 725021
RivastigmineRIVASTIGMINEMylan Pharmaceuticals Inc.4ab335d1-19ee-4cd9-9776-8086645d19e42024-09-21Warnings, Adverse reactionsExact identifier
rxcui: 725021
Rivastigmine Transdermal SystemRIVASTIGMINEBryant Ranch Prepack82630f84-fb47-47ab-8ee2-1720a486de022024-08-19Warnings, Adverse reactionsExact identifier
rxcui: 725021
RivastigmineRIVASTIGMINEAmneal Pharmaceuticals LLC8b671fc9-8cb0-4406-a9ee-7c95086d62002024-07-02Warnings, Adverse reactionsExact identifier
rxcui: 725021
RivastigmineRIVASTIGMINEZydus Pharmaceuticals USA Inc.64dad603-2389-456b-8c18-d1d40b7e74192024-05-27Warnings, Adverse reactionsExact identifier
rxcui: 725021
RivastigmineRIVASTIGMINESandoz Inc92a58ebb-748d-49f4-bf11-ecbcf54241522024-05-08Warnings, Adverse reactionsExact identifier
rxcui: 725021
ExelonRIVASTIGMINENovartis Pharmaceuticals Corporation07c12e14-bbd5-4ec8-84e4-fbe7b5ba10e02024-05-08Warnings, Adverse reactionsExact identifier
rxcui: 725021
ExelonRIVASTIGMINESandoz Incb6ed6d15-116d-4596-92ce-3414574d7ba02024-05-08Warnings, Adverse reactionsExact identifier
rxcui: 725021

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 14 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
82630f84-fb47-47ab-8ee2-1720a486de02rivastigmine 4.6 MG/Day 24HR Transdermal System [PSN] · 24 HR rivastigmine 0.192 MG/HR Transdermal System [SCD] · rivastigmine 0.192 MG/HR 24 HR Transdermal Patch [SY] · rivastigmine 4.6 MG/Day 24 HR Transdermal Patch [SY] · rivastigmine 4.6 MG/Day 24HR Transdermal System [SY]5108These highlights do not include all the information needed to use RIVASTIGMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for RIVASTIGMINE TRANSDERMAL SYSTEM. RIVASTIGMINE transdermal system Initial U.S. Approval: 200020240819
a7f9328e-b6da-4474-ac93-3cdd4825e163rivastigmine 4.6 MG/Day 24HR Transdermal System [PSN] · 24 HR rivastigmine 0.192 MG/HR Transdermal System [SCD] · rivastigmine 0.192 MG/HR 24 HR Transdermal Patch [SY] · rivastigmine 4.6 MG/Day 24 HR Transdermal Patch [SY] · rivastigmine 4.6 MG/Day 24HR Transdermal System [SY]5102These highlights do not include all the information needed to use RIVASTIGMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for RIVASTIGMINE TRANSDERMAL SYSTEM. RIVASTIGMINE transdermal system Initial U.S. Approval: 200020250401
07c12e14-bbd5-4ec8-84e4-fbe7b5ba10e0rivastigmine 4.6 MG/Day 24HR Transdermal System [PSN] · 24 HR rivastigmine 0.192 MG/HR Transdermal System [SCD] · rivastigmine 0.192 MG/HR 24 HR Transdermal Patch [SY] · rivastigmine 4.6 MG/Day 24 HR Transdermal Patch [SY] · rivastigmine 4.6 MG/Day 24HR Transdermal System [SY]530These highlights do not include all the information needed to use EXELON PATCH safely and effectively. See full prescribing information for EXELON PATCH. EXELON ® PATCH (rivastigmine transdermal system) Initial U.S. Approval: 200020240508
8b671fc9-8cb0-4406-a9ee-7c95086d6200rivastigmine 4.6 MG/Day 24HR Transdermal System [PSN] · 24 HR rivastigmine 0.192 MG/HR Transdermal System [SCD] · rivastigmine 0.192 MG/HR 24 HR Transdermal Patch [SY] · rivastigmine 4.6 MG/Day 24 HR Transdermal Patch [SY] · rivastigmine 4.6 MG/Day 24HR Transdermal System [SY]517These highlights do not include all the information needed to use RIVASTIGMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for RIVASTIGMINE TRANSDERMAL SYSTEM. RIVASTIGMINE transdermal system Initial U.S. Approval: 200020240702
4ab335d1-19ee-4cd9-9776-8086645d19e4rivastigmine 4.6 MG/Day 24HR Transdermal System [PSN] · 24 HR rivastigmine 0.192 MG/HR Transdermal System [SCD] · rivastigmine 0.192 MG/HR 24 HR Transdermal Patch [SY] · rivastigmine 4.6 MG/Day 24 HR Transdermal Patch [SY] · rivastigmine 4.6 MG/Day 24HR Transdermal System [SY]510These highlights do not include all the information needed to use RIVASTIGMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for RIVASTIGMINE TRANSDERMAL SYSTEM. RIVASTIGMINE transdermal system Initial U.S. Approval: 200020240921
8b809739-8381-4cc1-ab4a-5b17ab902a3drivastigmine 4.6 MG/Day 24HR Transdermal System [PSN] · 24 HR rivastigmine 0.192 MG/HR Transdermal System [SCD] · rivastigmine 0.192 MG/HR 24 HR Transdermal Patch [SY] · rivastigmine 4.6 MG/Day 24 HR Transdermal Patch [SY] · rivastigmine 4.6 MG/Day 24HR Transdermal System [SY]57These highlights do not include all the information needed to use RIVASTIGMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for RIVASTIGMINE TRANSDERMAL SYSTEM. Rivastigmine Transdermal System Initial U.S. Approval: 200020251114
b201fe68-b5e5-4a6f-8cf1-069543f03e76rivastigmine 4.6 MG/Day 24HR Transdermal System [PSN] · 24 HR rivastigmine 0.192 MG/HR Transdermal System [SCD] · rivastigmine 0.192 MG/HR 24 HR Transdermal Patch [SY] · rivastigmine 4.6 MG/Day 24 HR Transdermal Patch [SY] · rivastigmine 4.6 MG/Day 24HR Transdermal System [SY]57These highlights do not include all the information needed to use RIVASTIGMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for RIVASTIGMINE TRANSDERMAL SYSTEM. RIVASTIGMINE transdermal system Initial U.S. Approval: 200020250115
92a58ebb-748d-49f4-bf11-ecbcf5424152rivastigmine 4.6 MG/Day 24HR Transdermal System [PSN] · 24 HR rivastigmine 0.192 MG/HR Transdermal System [SCD] · rivastigmine 0.192 MG/HR 24 HR Transdermal Patch [SY] · rivastigmine 4.6 MG/Day 24 HR Transdermal Patch [SY] · rivastigmine 4.6 MG/Day 24HR Transdermal System [SY]55These highlights do not include all the information needed to use RIVASTIGMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for RIVASTIGMINE TRANSDERMAL SYSTEM. RIVASTIGMINE TRANSDERMAL SYSTEM Initial U.S. Approval: 200020240508
64dad603-2389-456b-8c18-d1d40b7e7419rivastigmine 4.6 MG/Day 24HR Transdermal System [PSN] · 24 HR rivastigmine 0.192 MG/HR Transdermal System [SCD] · rivastigmine 0.192 MG/HR 24 HR Transdermal Patch [SY] · rivastigmine 4.6 MG/Day 24 HR Transdermal Patch [SY] · rivastigmine 4.6 MG/Day 24HR Transdermal System [SY]54These highlights do not include all the information needed to use RIVASTIGMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for RIVASTIGMINE TRANSDERMAL SYSTEM. Rivastigmine Transdermal System Initial U.S. Approval: 200020240527
7d8414f5-b51f-4ccb-b7a1-83b9ede5b266rivastigmine 4.6 MG/Day 24HR Transdermal System [PSN] · 24 HR rivastigmine 0.192 MG/HR Transdermal System [SCD] · rivastigmine 0.192 MG/HR 24 HR Transdermal Patch [SY] · rivastigmine 4.6 MG/Day 24 HR Transdermal Patch [SY] · rivastigmine 4.6 MG/Day 24HR Transdermal System [SY]53These highlights do not include all the information needed to use RIVASTIGMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for RIVASTIGMINE TRANSDERMAL SYSTEM. Rivastigmine Transdermal System Initial U.S. Approval: 200020221004
29481887-34eb-460a-bd7f-b8755473065arivastigmine 4.6 MG/Day 24HR Transdermal System [PSN] · 24 HR rivastigmine 0.192 MG/HR Transdermal System [SCD] · rivastigmine 0.192 MG/HR 24 HR Transdermal Patch [SY] · rivastigmine 4.6 MG/Day 24 HR Transdermal Patch [SY] · rivastigmine 4.6 MG/Day 24HR Transdermal System [SY]5220100222
966d59ea-5cea-4fef-8b96-e0efe885caf4rivastigmine 4.6 MG/Day 24HR Transdermal System [PSN] · 24 HR rivastigmine 0.192 MG/HR Transdermal System [SCD] · rivastigmine 0.192 MG/HR 24 HR Transdermal Patch [SY] · rivastigmine 4.6 MG/Day 24 HR Transdermal Patch [SY] · rivastigmine 4.6 MG/Day 24HR Transdermal System [SY]51Rivastigmine Transdermal System20251117
b6ed6d15-116d-4596-92ce-3414574d7ba0rivastigmine 4.6 MG/Day 24HR Transdermal System [PSN] · 24 HR rivastigmine 0.192 MG/HR Transdermal System [SCD] · rivastigmine 0.192 MG/HR 24 HR Transdermal Patch [SY] · rivastigmine 4.6 MG/Day 24 HR Transdermal Patch [SY] · rivastigmine 4.6 MG/Day 24HR Transdermal System [SY]51These highlights do not include all the information needed to use EXELON PATCH safely and effectively. See full prescribing information for EXELON PATCH. EXELON ® PATCH (rivastigmine transdermal system) Initial U.S. Approval: 200020240508
5d7c4d41-2df4-42d4-9a3d-0a567519bf2drivastigmine 4.6 MG/Day 24HR Transdermal System [PSN] · 24 HR rivastigmine 0.192 MG/HR Transdermal System [SCD] · rivastigmine 0.192 MG/HR 24 HR Transdermal Patch [SY] · rivastigmine 4.6 MG/Day 24 HR Transdermal Patch [SY] · rivastigmine 4.6 MG/Day 24HR Transdermal System [SY]51Exelon20101220